PeaceHealth to Construct 67,000 Square-Foot Rehab Hospital in Springfield
PeaceHealth has received approval to construct a 67,000-square-foot rehabilitation hospital in Springfield, Oregon. The facility, majority owned by PeaceHealth and operated by LifePoint Rehabilitation, will provide physical, speech, and occupational therapies for individuals who have experienced catastrophic medical events. The estimated cost of the project is $72 million, with completion expected by January 2026. The new hospital will include the region’s first brain injury unit and address a significant community need for inpatient rehabilitation services.
Study Finds Inappropriate Diagnosis of Pneumonia Common in Hospitalized Adults
Inappropriate diagnosis of community-acquired pneumonia (CAP) in hospitalized adults is common, especially among older adults and those with dementia, according to a study published in JAMA Internal Medicine. The study found that 12.0 percent of hospitalized patients treated for CAP met criteria for inappropriate diagnosis, with 87.6 percent receiving full antibiotic courses. The study highlights the importance of accurate diagnosis and appropriate antibiotic treatment to minimize the risks associated with underdiagnosis and overdiagnosis of CAP.
UW Health, UnityPoint Health, and Lifepoint Rehabilitation to Develop Second Inpatient Rehabilitation Hospital in Wisconsin
UW Health, UnityPoint Health – Meriter Hospital, and Lifepoint Rehabilitation are partnering to develop a new freestanding inpatient rehabilitation hospital in Fitchburg, Wis. The facility will offer specialized care for adults recovering from neurological disease, stroke, brain or spinal cord injury, and other conditions. This expansion aims to address the growing need for rehabilitation services in the region, with an anticipated opening in 2026.
RSV Passive Immunization 69% Effective in Protecting Infants
The Eurosurveillance Rapid Communication published a study on January 25, 2024, that concluded Beyfortus™ (Nirsevimab) was about 69% effective at preventing pediatric respiratory syncytial virus (RSV) hospitalizations in infants. This study provides early real-world evidence of nirsevimab immunization protecting infants from severe RSV disease in Luxembourg, with a significant decrease in RSV cases among infants under six months old.
Cedars-Sinai Develops Pioneering Method to Identify Dementia Patients in Hospitals Using Electronic Health Records
Cedars-Sinai, a leading medical institution, has developed a pioneering method to identify hospitalized patients likely to have dementia using electronic health records. This innovative approach aims to improve the care provided to these vulnerable patients. The study, published in the…